Suppr超能文献

运用化学及化学工具探究和操控肠道微生物群。

Probing and manipulating the gut microbiome with chemistry and chemical tools.

作者信息

Mantravadi Pavan K, Kovi Basavaraj S, Reddy Sabbasani Rajasekhara, Namasivayam Ganesh Pandian, Kalesh Karunakaran, Parthasarathy Anutthaman

机构信息

CMC and Analytical, Cytokinetics, South San Francisco, CA, USA.

Institute for Integrated Cell-Material Sciences (ICeMS), Kyoto University, Kyoto, Japan.

出版信息

Gut Microbiome (Camb). 2025 Apr 14;6:e6. doi: 10.1017/gmb.2025.4. eCollection 2025.

Abstract

The human gut microbiome represents an extended "second genome" harbouring about 10 microbes containing >100 times the number of genes as the host. States of health and disease are largely mediated by host-microbial metabolic interplay, and the microbiome composition also underlies the differential responses to chemotherapeutic agents between people. Chemical information will be the key to tackle this complexity and discover specific gut microbiome metabolism for creating more personalised interventions. Additionally, rising antibiotic resistance and growing awareness of gut microbiome effects are creating a need for non-microbicidal therapeutic interventions. We classify chemical interventions for the gut microbiome into categories like molecular decoys, bacterial conjugation inhibitors, colonisation resistance-stimulating molecules, "prebiotics" to promote the growth of beneficial microbes, and inhibitors of specific gut microbial enzymes. Moreover, small molecule probes, including click chemistry probes, artificial substrates for assaying gut bacterial enzymes and receptor agonists/antagonists, which engage host receptors interacting with the microbiome, are some other promising developments in the expanding chemical toolkit for probing and modulating the gut microbiome. This review explicitly excludes "biologics" such as probiotics, bacteriophages, and CRISPR to concentrate on chemistry and chemical tools like chemoproteomics in the gut-microbiome context.

摘要

人类肠道微生物群代表了一个扩展的“第二基因组”,其中含有约10种微生物,其基因数量是宿主的100倍以上。健康和疾病状态在很大程度上由宿主 - 微生物代谢相互作用介导,而且微生物群组成也是人与人之间对化疗药物产生不同反应的基础。化学信息将是解决这种复杂性并发现特定肠道微生物群代谢以制定更个性化干预措施的关键。此外,抗生素耐药性的上升以及对肠道微生物群影响的认识不断提高,使得人们需要非杀菌性治疗干预措施。我们将针对肠道微生物群的化学干预措施分为以下几类:分子诱饵、细菌结合抑制剂、刺激定植抗性的分子、促进有益微生物生长的“益生元”以及特定肠道微生物酶的抑制剂。此外,小分子探针,包括点击化学探针、用于检测肠道细菌酶的人工底物以及与与微生物群相互作用的宿主受体结合的受体激动剂/拮抗剂,是用于探测和调节肠道微生物群的不断扩展的化学工具包中的其他一些有前景的进展。本综述明确排除了益生菌、噬菌体和CRISPR等“生物制品”,而专注于肠道微生物群背景下的化学和化学工具,如化学蛋白质组学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c706/12056425/cd11bf13c948/S2632289725000040_figAb.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验